胃癌是一种高发的恶性肿瘤,是癌症相关死亡的第二大病因.早期筛查是提高患者生存率的有效手段,但目前临床上尚缺乏实现胃癌无创筛检的可靠标志物.本研究采用了基于液相色谱-质谱联用的拟靶向代谢组学方法分析了20例胃癌患者及40例正常人血清代谢组,以期发现新的潜在代谢标志物.代谢组数据的主成分分析和偏最小二乘法数据分析结果显示,胃癌患者与健康人群的血清代谢组存在明显的差异,结合非参数检验进一步筛选并定性出57个差异代谢物.其中二氢胆固醇经验证组样本验证,具有成为胃癌代谢标志物的潜力.本研究在发现胃癌的潜在代谢标志物的同时,也为胃癌患者代谢分型提供了重要的科学依据.
参考文献
[1] | Parkin D M,Bray F,Ferlay J,et al.CA Cancer J Clin,2005,55(2):74 |
[2] | Genta R M.Aliment Pharmacol Ther,2004,20(2):42 |
[3] | Marrelli D,Roviello F,De Stefano A.et al.Oncology,1999,57(1):55 |
[4] | Karl-Heinz O,Nelly A,Singh B,et al.Phytochemistry,2003,62(6):971 |
[5] | Nicholson J K,Connelly J,Lindon J C,et al.Nat Rev Drug Discov,2002,1(2):153 |
[6] | Holmes E,Wilson I D,Nicholson J K.Cell,2008,135(5):714 |
[7] | Zhu Y Z,Feng Y N,Jin Z H.Chinese Journal of Chromatography(朱永哲,冯雅男,金正汉,等.色谱),2013,31(9):850 |
[8] | Dai W D,Zhang F X,Jia Z H,et al.Chinese Journal of Chromatography(戴伟东,张凤霞,贾振华,等.色谱),2011,29(11):1049 |
[9] | Yin P,Xu G.Expert Rev Mol Diagn,2013,13(4):339 |
[10] | RainerL,ZhaoX,CoraW,et al.Plos One,2010,5(7):e11519 |
[11] | Anderson L,Hunter C L.Mol Cell Proteomics,2006,5(4):573 |
[12] | Li Y,Ruan Q,Li Y L,et al.J Chromatogr A,2012,1255:228 |
[13] | ChenSL,Kong H W,Lu X,et al.Anal Chem,2013,85(17):8326 |
[14] | Zhao Y,Zhao C,Lu X,et al.J Proteome Res,2013,12(11):5072 |
[15] | Zhou L N,Ding L L,Yin P Y,et al.J Proteome Res,2012,11(11):5433 |
[16] | Yin P Y,Wan D F,Zhao C X,et al.Mol Biosyst,2009,5(8):868 |
[17] | Zhao X,Fritsche J,Wang J,et al.Metabolomics,2010,6(3):362 |
[18] | Chen J,Zhao X,Fritsche J,et al.Anal Chem,2008,80(4):1280 |
[19] | Zhao S M,Wang Y S,Dou A B,et al.Chinese Journal of Chromatography(赵素敏,王宜生,窦阿波,等.色谱),2011,29(9):843 |
[20] | Dong J,Cai X M,Zhao L L,et al.Metabolomics,2010,6(4):478 |
[21] | Zhao Z,Xiao Y,Elson P,et al.J Clin Oncol,2007,25(19):2696 |
[22] | Mills G B,Moolenaar W H.Nat Rev Cancer,2003,3 (8):582 |
[23] | Zhou L,Wang Q,Yin P,et al.Anal Bioanal Chem,2012,403(1):203 |
上一张
下一张
上一张
下一张
计量
- 下载量()
- 访问量()
文章评分
- 您的评分:
-
10%
-
20%
-
30%
-
40%
-
50%